<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tblu22" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="top">Group 1</th><th valign="top">Group 2</th><th valign="top">Number of <break/>simulations</th><th valign="top">A priori power</th><th valign="top">Group 1 <break/>sample size</th><th valign="top">Group 2 <break/>sample size</th></tr></thead><tbody><tr><td valign="top">Drug-na&#239;ve PC9 cells</td><td valign="top">PC9 DTPs</td><td valign="top">10,000<sup>1</sup></td><td valign="top">99.9%</td><td valign="top">2<sup>2</sup></td><td valign="top">2<sup>2</sup></td></tr></tbody></table><table-wrap-foot><fn id="tblfn4"><p><sup>1</sup> The estimated data was used to create simulated data sets with preserved sampling structure assuming a normal distribution. For a given <italic>n</italic> (the number of replicates) 10,000 simulations were run and Mantel-Haenszel chi-squared value was calculated for each simulated data set. The power was then calculated by counting the number of times <italic>p</italic>&#8804;0.05 and dividing by 10,000.</p></fn><fn id="tblfn5"><p><sup>2</sup> A sample size of 3 per group will be used based on the percent of sub-G1 cells analysis.</p></fn></table-wrap-foot></table-wrap>